Winners, Inc. (WNRS)
OTC PINK OTC PINK Primary 
Top Tech Analyst Says Hyperscalers Are the Clear AI Winners, but Beaten-Down Software Offers Value
Constellation Research Chairman Ray Wang went on CNBC Monday morning to argue that the AI capital cycle has split the megacaps into two camps: hyperscalers with a clear line of sight to AI monetization, and enterprise software names that have been sold off despite growing cash flows.
AI's Biggest Winners Today Will Share the Spotlight as Technology Spreads Across the Entire Market
The host's argument on Investing Insights lands with a specific market backdrop: Large AI companies like NVIDIA (NASDAQ:NVDA | NVDA Price Prediction) and Microsoft (NASDAQ:MSFT) dominate indexes right now, but the buildout underneath is quietly minting a second tier of beneficiaries in power generation and industrial metals.
The AI Boom Is Expanding Beyond Chips. These 3 ETFs Could Be the Next Winners
Artificial intelligence has fueled one of the strongest stock market rallies in recent years, with semiconductor companies leading much of the market's gains in 2026.
The Next AI Winners May Not Be the Magnificent Seven: 3 Mid-Cap ETFs to Watch
Artificial intelligence has been one of the market's most powerful investment themes over the past several years, helping propel the so-called Magnificent Seven stocks to enormous gains.
6 High‑Risk Stocks That Could Be Big Winners
Retail investors are searching for the next big winners — and Jessica Inskip says the opportunity sits inside one emerging theme: interconnectivity. She breaks down her top high‑risk, high‑reward picks and explains why tokenized securities, stablecoin settlement, and new trading rails could unlock major upside.
Premium Retail's Stress Test Is Separating Winners From Losers
Premium consumer brands, once a stable bet even in times of market volatility, are no longer quite so insulated from broader economic pressures. Investors have increasingly begun to separate companies, favoring those with true pricing power and brand momentum over those that have struggled as demand has weakened amid slower discretionary spending, inflation, tariff uncertainty, and other factors.
The American Chip Boom Picks Winners: TXN, INTC, and QRVO at Current Prices
TXN pulled in $850M in Q2 CHIPS incentives. Intel is ramping 18A high-volume manufacturing in Arizona and Oregon, backed by a US government equity stake and a $5B NVIDIA investment related to AI infrastructure.
Q2 Earnings: 2 Winners and 1 Loser So Far
So far in the Q2 cycle, several companies, including Micron and Citigroup, have been standouts, whereas preliminary results from IBM have been disappointing.
The Trump Administration Presses for More Memory Plants in America: These 3 Stocks Could Be Winners
The Trump administration is pressuring foreign memory chipmakers to expand their U.S.
These 3 Water ETFs Could be Quiet Winners From Infrastructure Spending
Data centers receive sharp criticism for their high water usage, but the impact on the broader water industry and for investors is also about infrastructure bottlenecks, regulation, and emerging technologies, among other things. Utilities companies must navigate significant changes when hyperscalers enter their territory—in some cases, a new data center operator may immediately become one of the largest customers in the region.
The Hidden Winners Inside SCHD - July 2026
SCHD has returned just under 2% in the past month, outperforming the S&P 500 ETF SPY by almost 100 bps. Year-to-date, almost 30 SCHD holdings have a return that's more than double that of SPY which has returned 9.8% YTD. 31 SCHD holdings look to be trading for an attractive valuation, in that they are at least 10% undervalued but also have a potential future return of above 10%.
The Phase 3 Failure That Sent Biotech Winners and Losers in Opposite Directions
When a late-stage clinical trial misses a primary endpoint, the market reaction rarely distributes evenly across the board. The fallout often reveals undeniable fundamental truths about single-asset exposure, pipeline diversification, and the competitive moats protecting established treatments.
